1 reports of this reaction
20.0% of all BAPTISIA TINCTORIA ROOT reports
#5 most reported adverse reaction
URTICARIA is the #5 most commonly reported adverse reaction for BAPTISIA TINCTORIA ROOT, manufactured by ACTAVIS PHARMA, INC.. There are 1 FDA adverse event reports linking BAPTISIA TINCTORIA ROOT to URTICARIA. This represents approximately 20.0% of all 5 adverse event reports for this drug.
Patients taking BAPTISIA TINCTORIA ROOT who experience urticaria should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
URTICARIA is a frequently reported adverse event for BAPTISIA TINCTORIA ROOT, accounting for a significant proportion of all reports.
In addition to urticaria, the following adverse reactions have been reported for BAPTISIA TINCTORIA ROOT:
The following drugs have also been linked to urticaria in FDA adverse event reports:
URTICARIA has been reported as an adverse event in 1 FDA reports for BAPTISIA TINCTORIA ROOT. This does not prove causation, but indicates an association observed in post-market surveillance data.
URTICARIA accounts for approximately 20.0% of all adverse event reports for BAPTISIA TINCTORIA ROOT, making it a notable side effect.
If you experience urticaria while taking BAPTISIA TINCTORIA ROOT, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.